| [1] |
马飞，黎立喜. 肿瘤全方位全周期健康管理[J]. 中华医学杂志，2024，104(2) : 100-106.
|
| [2] |
Greiber IK, Viuff JH, Mellemkjaer L, et al. Cancer in pregnancy and the risk of adverse pregnancy and neonatal outcomes: a nationwide cohort study[J]. BJOG，2022，129(9)：1492-1502.
|
| [3] |
Wen T, Fish MG, Friedman AM. Trends and outcomes associated with cancer diagnoses during delivery hospitalizations[J]. Semin Perinatol，2025，49(2)：152046.
|
| [4] |
Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent，2024，4(1)：47-53.
|
| [5] |
Chen DW, Haymart MR. Unravelling the rise in thyroid cancer incidence and addressing overdiagnosis[J]. Nat Rev Endocrinol，2026，22(1)：10-20.
|
| [6] |
Turriff AE, Annunziata CM, Malayeri AA, et al. Prenatal cfDNA sequencing and incidental detection of maternal cancer[J]. N Engl J Med，2024，391(22)：2123-2132.
|
| [7] |
Nanda S, Nana M, Nguyen-Hoang L, et al. Cancer in pregnancy: FIGO best practice advice and narrative review[J]. Int J Gynaecol Obstet，2025，171(1)：131-151.
|
| [8] |
刘琪，顾宁，杨玲，等. 妊娠合并恶性肿瘤的临床特征及母儿结局[J/OL]. 中华妇幼临床医学杂志(电子版)，2025，21(6)：634-642.
|
| [9] |
Suh E, Stratton KL, Leisenring WM, et al. Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the childhood cancer survivor study[J]. Lancet Oncol，2020，21(3)：421-435.
|
| [10] |
Baker KS, Syrjala KL. Long-term complications in adolescent and young adult leukemia survivors[J]. Hematology Am Soc Hematol Educ Program，2018，2018(1)：146-153.
|
| [11] |
Cynthia M, Sumaiya A, Lina B, et al. Pregnancy after cancer: FIGO best practice advice[J]. Int J Gynaecol Obstet，2025，169(3)：1119-1126.
|
| [12] |
Kanbergs A, Clapp M, Wu C, et al. Cancer diagnosis during pregnancy is associated with severe maternal and neonatal morbidity[J]. Am J Obstet Gynecol，2025，232(5)：466.e1-466.e29.
|
| [13] |
Leproux C, Seegers V, Patsouris A, et al. Success and risks of pregnancy after breast cancer[J]. Breast Cancer Res Treat，2021，188(3)：593-600.
|
| [14] |
Partridge AH, Niman SM, Ruggeri M, et al. Interrupting endocrine therapy to attempt pregnancy after breast cancer[J]. N Engl J Med，2023，388(18)：1645-1656.
|
| [15] |
Amant F, Berveiller P, Boere IA, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting[J]. Ann Oncol，2019，30(10)：1601-1612.
|
| [16] |
柳华，戴毅敏．妊娠期胃癌七例临床分析[J]. 中华妇产科杂志，2019，54(7)：484-487.
|
| [17] |
方婧，肖镇冬，徐修云，等. 妊娠期急性白血病9例临床分析[J]. 中华妇产科杂志，2024，59(9)：719-722.
|
| [18] |
柳华，戴毅敏．妊娠合并非霍奇金淋巴瘤7例临床分析[J].中华妇产科杂志，2023，58(3)：207-212.
|
| [19] |
Committee on Obstetric Practice. Committee opinion No.723: guidelines for diagnostic imaging during pregnancy and lactation[J]. Obstet Gynecol，2017，130(4)：e210-216.
|
| [20] |
徐修云，仇黎丽，谢丽，等. 妊娠合并晚期乳腺恶性肿瘤1例[J]. 中国临床案例成果数据库，2024，6(1)：E0140.
|
| [21] |
Lenaerts L, Brison N, Maggen C, et al. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: a single-center retrospective analysis of over 85，000 pregnancies[J]. EClinicalMedicine，2021，35：100856.
|
| [22] |
Heesterbeek CJ, Aukema SM, Galjaard RH, et al. Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study[J]. J Clin Oncol，2022，40(22)：2426-2435.
|
| [23] |
Metcalfe A, Cairncross ZF, McMorris CA, et al. Cancer chemotherapy in pregnancy and adverse pediatric outcomes: a population-based cohort study[J]. J Natl Cancer Inst，2025，117(3)：554-561.
|
| [24] |
Van Assche IA, Huis In′t Veld EA, Van Calsteren K, et al. Cognitive and behavioral development of 9-year-old children after maternal cancer during pregnancy: a prospective multicenter cohort study[J]. J Clin Oncol，2023，41(8)：1527-1532.
|
| [25] |
Struys I, Velázquez C, Ubels J, et al. Prenatal exposure to chemotherapy increases the mutation burden in human neonatal hematopoietic stem cells[J]. Cancer Discov，2025，15(5)：903-912.
|
| [26] |
中华医学会外科学分会乳腺外科学组. 中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)[J]. 中国实用外科杂志，2022，42(2)：146-150.
|
| [27] |
中国抗癌协会宫颈癌专业委员会，中国医师协会妇产科医师分会，卢淮武，等．妊娠合并子宫颈癌诊治指南(2024年版)[J]. 中国实用妇科与产科杂志，2024，40(10)：1003-1012.
|
| [28] |
Baldwin EA, Borowski KS, Brost BC, et al. Antepartum nonobstetrical surgery at ≥23 weeks′ gestation and risk for preterm delivery[J]. Am J Obstet Gynecol，2015，212(2)：232.e1-232.e5.
|
| [29] |
Amant F, Planchamp F, Berveiller P, et al. ESGO/INCIP Guidelines for the management of patients with gynecological cancers during pregnancy[J]. Int J Gynecol Cancer，2025，35(9)：101975.
|
| [30] |
Lambertini M, Peccatori FA, Azim HA. Targeted agents for cancer treatment during pregnancy[J]. Cancer Treat Rev，2015，41(4)：301-309.
|
| [31] |
Borgers JSW, Heimovaara JH, Cardonick E, et al. Immunotherapy for cancer treatment during pregnancy[J]. Lancet Oncol，2021，22(12)：e550-561.
|
| [32] |
Baarslag MA, Heimovaara JH, Borgers JSW, et al. Severe immune-related enteritis after in utero exposure to pembrolizumab[J]. N Engl J Med，2023，389(19)：1790-1796.
|
| [33] |
Gougis P, Hamy A, Jochum F, et al. Immune checkpoint inhibitor use during pregnancy and outcomes in pregnant individuals and newborns[J]. JAMA Netw Open，2024，7(4)：e245625.
|
| [34] |
Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy[J]. N Engl J Med，2015，373(19)：1824-1834.
|